Narlaprevir is an antiviral agent and a potent inhibitor of the NS3/4A serine protease, used in combination therapies for the treatment of chronic hepatitis C genotype 1 infection. This category features… Read more
![Chemical structure of (1R,2S,5S)-3-((S)-2-(3-(1-((tert-Butylsulfonyl)methyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1229337-32-9-1R2S5S-3-S-2-3-1-tert-Butylsulfonylmethylcyclohexylureido-33-dimethylbutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-3-((S)-2-(3-(1-((tert-Butylsulfonyl)methyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-N-((2S,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxoheptan-3-yl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1256345-29-5-1R2S5S-3-S-2-3-1-tert-Butylsulfonylmethylcyclohexylureido-33-dimethylbutanoyl-N-2S3S-1-cyclopropylamino-2-hydroxy-1-oxoheptan-3-yl-66-dim.png&w=3840&q=75)

![Chemical structure of Methyl (1R,2S,5S)-3-((S)-2-(3-(1-((tert-butylsulfonyl)methyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1208245-88-8-Methyl-1R2S5S-3-S-2-3-1-tert-butylsulfonylmethylcyclohexylureido-33-dimethylbutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxylate.png&w=3840&q=75)

Narlaprevir is an antiviral agent and a potent inhibitor of the NS3/4A serine protease, used in combination therapies for the treatment of chronic hepatitis C genotype 1 infection. This category features high-quality reference standards essential for comprehensive pharmaceutical analysis, including Narlaprevir API, related impurities, and relevant metabolites. Analytical laboratories utilize these compounds to conduct impurity profiling and method validation, ensuring accurate quantification and characterization throughout drug development. The inclusion of stable isotope labelled compounds provides critical internal standards for mass spectrometry-based assays, facilitating precise tracking and identification in complex matrices. By providing these specific materials, analytical teams can maintain rigorous quality control standards, support stability testing, and comply with regulatory requirements for safety and efficacy in the production of antiviral treatments.